SRPT vs ZBRA · rev $1.13B vs P/E 28, rev $3.05B
Sarepta Therapeutics Inc (SRPT) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
SRPT currently screens at market cap $2.34B. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the SRPT and ZBRA stock pages for the full models.
Not investment advice.